Company Profile

LNKChemsolutions LLC
Profile last edited on: 9/2/2023      CAGE:       UEI:

Business Identifier: Nanoparticle and nanofiber research & development
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

6401 Alpine Road
Denton, NE 68339
   (402) 416-1811
Location: Single
Congr. District: 01
County: Lancaster

Public Profile

LNKChemsolutions LLC, spun out of technology developed at the University of Nebraska-Lincoln, is doing research & development for nanoparticle and nanofiber applications, such as toxicology, tissue engineering, encapsulation, and controlled release. The company has developed a system of submicron tubules, fibers, and solid and hollow spheres, created from a very large variety of inorganic, organic and biological materials, Hierarchical control of structure is also conducted to produced materials with superior structure-function relationships. Many product lines including food, biomedical, and catalysis applications are being developed to provide the modern industry with nanotech solutions that meet new product performance challenges and possess proprietary nanofiber design technology.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 2 NIH $2,374,002
Project Title: Nanoparticles And Nanocapsules For Glioma Targeting
2013 2 NIH $296,413
Project Title: Development of Ultrafine Particles for Intranasal Delivery of Antipsychotics
2010 2 NIH $399,994
Project Title: Development Of New Hemostatic Dressings
2010 1 CBD $70,000
Project Title: Improved Formulations to Enhance Bio-availability for Antisense Therapeutics
2006 1 NSF $100,000
Project Title: Nanoengineered Encapsulation of Therapeutics

Key People / Management

  Gustavo F Larsen -- President

  Rajinder Gill

  Sandra Edith Noriega

  Luis Nunez

  Raffet Velarde Ortiz

  Ruben Spretz

Company News

There are no news available.